Linc AB
Overview
Linc AB is a Swedish investment firm that invests in product-oriented companies in the Nordic life science industry, primarily focusing on pharmaceuticals and medical technology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Gesynta Pharma AB | Jul 2025 | Series B | Co-investor |
| Synartro AB | Oct 2024 | VC Round | Co-investor |
| Akiram Therapeutics | Jan 2023 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Linc AB based?
Linc AB is headquartered in Stockholm, Sweden.
When was Linc AB founded?
Linc AB was founded in 1991.
How many portfolio companies does Linc AB have?
Linc AB has 6 portfolio companies in Caplight's dataset.
What are some companies in Linc AB's portfolio?
Recent investments visible on Caplight include Gesynta Pharma AB, Gesynta Pharma AB, Synartro AB, Synartro AB, Akiram Therapeutics.
What was Linc AB's most recent investment?
Linc AB's most recent investment on Caplight was in Gesynta Pharma AB in 2025.
What sectors does Linc AB focus on?
Linc AB focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Linc AB focus on?
Linc AB typically invests at the MultiStage stage.